Heritage and PhyeinMed Submit Evidence Package
Vancouver, B.C., May 24, 2018 / TheNewswire / HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce that its subsidiary PhyeinMed Inc. (“PhyeinMed”), has submitted to Health Canada, the evidence of site and facility completion as noted in the letter ‘Confirmation of Readiness under the ACMPR’. This is the final step of the application process, with the next step being PhyeinMed receiving a production license and approval to cultivate cannabis at their location in Falkland, British Columbia.
“I am very proud of the discipline and diligence that our PhyeinMed team showed in preparing this Evidence Package” says Jagdip Bal, CEO of Heritage “the rules and regulations surrounding obtaining a licence to produce are challenging and detailed, however we are confident our team understood these requirements and produced a detailed and complete submission.”
The Company now awaits feedback from Health Canada and will update shareholders in the future as it continues to move forward and prepare for the upcoming legalization of cannabis in Canada.
About Heritage Cannabis Holdings Corporation
The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a parent and Development Company with strategic plans to continue to acquire Cannabis related companies.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION
President and CEO
For more information contact:
The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.